X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES AUROBINDO PHARMA JUBILANT LIFE SCIENCES/
AUROBINDO PHARMA
 
P/E (TTM) x 26.2 14.6 178.8% View Chart
P/BV x 5.4 3.8 143.0% View Chart
Dividend Yield % 0.3 0.4 81.5%  

Financials

 JUBILANT LIFE SCIENCES   AUROBINDO PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
AUROBINDO PHARMA
Mar-17
JUBILANT LIFE SCIENCES/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs187895 20.9%   
Low Rs65622 10.5%   
Sales per share (Unadj.) Rs364.3254.6 143.1%  
Earnings per share (Unadj.) Rs6.839.3 17.4%  
Cash flow per share (Unadj.) Rs24.546.6 52.6%  
Dividends per share (Unadj.) Rs3.002.50 120.0%  
Dividend yield (eoy) %2.40.3 722.7%  
Book value per share (Unadj.) Rs164.9160.0 103.1%  
Shares outstanding (eoy) m159.28585.88 27.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.33.0 11.6%   
Avg P/E ratio x18.419.3 95.3%  
P/CF ratio (eoy) x5.116.3 31.6%  
Price / Book Value ratio x0.84.7 16.1%  
Dividend payout %43.86.4 688.5%   
Avg Mkt Cap Rs m20,061444,390 4.5%   
No. of employees `0006.214.0 44.2%   
Total wages/salary Rs m11,05217,678 62.5%   
Avg. sales/employee Rs Th9,383.010,667.8 88.0%   
Avg. wages/employee Rs Th1,786.91,264.3 141.3%   
Avg. net profit/employee Rs Th176.31,645.8 10.7%   
INCOME DATA
Net Sales Rs m58,034149,157 38.9%  
Other income Rs m1911,159 16.4%   
Total revenues Rs m58,224150,316 38.7%   
Gross profit Rs m5,78634,343 16.8%  
Depreciation Rs m2,8124,276 65.8%   
Interest Rs m3,237667 485.2%   
Profit before tax Rs m-7230,558 -0.2%   
Minority Interest Rs m-28650 -569.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6967,597 9.2%   
Profit after tax Rs m1,09023,012 4.7%  
Gross profit margin %10.023.0 43.3%  
Effective tax rate %-965.924.9 -3,885.4%   
Net profit margin %1.915.4 12.2%  
BALANCE SHEET DATA
Current assets Rs m29,28092,062 31.8%   
Current liabilities Rs m38,91266,223 58.8%   
Net working cap to sales %-16.617.3 -95.8%  
Current ratio x0.81.4 54.1%  
Inventory Days Days84106 79.6%  
Debtors Days Days5168 74.9%  
Net fixed assets Rs m55,71262,919 88.5%   
Share capital Rs m155586 26.4%   
"Free" reserves Rs m20,96893,133 22.5%   
Net worth Rs m26,26593,719 28.0%   
Long term debt Rs m17,1691,814 946.5%   
Total assets Rs m88,606162,494 54.5%  
Interest coverage x1.046.8 2.1%   
Debt to equity ratio x0.70 3,377.2%  
Sales to assets ratio x0.70.9 71.4%   
Return on assets %4.914.6 33.5%  
Return on equity %4.224.6 16.9%  
Return on capital %11.632.7 35.3%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00475,838 29.0%   
Fx outflow Rs m11,74930,224 38.9%   
Net fx Rs m10,25545,613 22.5%   
CASH FLOW
From Operations Rs m8,02632,786 24.5%  
From Investments Rs m-1,744-17,870 9.8%  
From Financial Activity Rs m-4,447-19,153 23.2%  
Net Cashflow Rs m1,834-4,239 -43.3%  

Share Holding

Indian Promoters % 45.6 54.1 84.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 8.0 109.4%  
FIIs % 21.2 27.7 76.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 10.2 206.9%  
Shareholders   23,815 69,601 34.2%  
Pledged promoter(s) holding % 15.9 8.6 185.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   WYETH LTD  IPCA LABS  NATCO PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Feb 23, 2018 03:35 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS